ELANCO ANIMAL HEALTH INC (5EA.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:5EA - US28414H1032 - Common Stock
5EA.DE Key Statistics, Chart & Performance
The current stock price of 5EA.DE is 18.358 EUR.
5EA.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.36 | 210.25B | ||
| SNW.DE | SANOFI | 11.34 | 209.38B | ||
| SAN.PA | SANOFI | 11.37 | 210.44B | ||
| MRK.DE | MERCK KGAA | 13.53 | 50.17B | ||
| UCB.BR | UCB SA | 36.78 | 45.92B | ||
| UNC.DE | UCB SA | 34.83 | 43.49B | ||
| 1BAYN.MI | BAYER AG-REG | 5.78 | 30.32B | ||
| BAYN.DE | BAYER AG-REG | 5.77 | 30.29B | ||
| IPN.PA | IPSEN | 12.47 | 10.74B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.74 | 10.60B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.78 | 9.34B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 98.08 | 9.08B |
Related stock screener links
About 5EA.DE
Company Profile
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. The company offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others
Company Info
ELANCO ANIMAL HEALTH INC
2500 Innovation Way N
Greenfield INDIANA US
Employees: 9000
Phone: 18773526261.0
ELANCO ANIMAL HEALTH INC / 5EA.DE FAQ
Can you describe the business of ELANCO ANIMAL HEALTH INC?
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. The company offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others
What is the stock price of ELANCO ANIMAL HEALTH INC today?
The current stock price of 5EA.DE is 18.358 EUR.
Does ELANCO ANIMAL HEALTH INC pay dividends?
5EA.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of 5EA stock?
5EA.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Should I buy 5EA stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 5EA.DE.
5EA.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 5EA.DE.
5EA.DE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
5EA.DE Forecast & Estimates
19 analysts have analysed 5EA.DE and the average price target is 25.57 EUR. This implies a price increase of 39.3% is expected in the next year compared to the current price of 18.358.